News & Media: All

Aug 22, 2016

Dana Goldman in the New York Times: Concierge Care Can Help Indigent Uninsured

In Dana Goldman's latest opinion piece for the New York Times, "Hospital Care for Those Who Can Afford It Helps Care for Those Who Can't," he examines the paradox of concierge care and how it may effect those without insurance.

To read the complete editorial, please click here.

Aug 17, 2016

Anupam Jena in The Guardian: Australia's New Drug Guidelines Put Cost-Cutting Before Patients

Precision Health Economics' Principal Scientific Advisor Anupam B. Jena discusses Australia's proposed new guidelines for the PBS (Pharmaceutical Benefit Scheme) in a new commentary for The Guardian.

To read the complete commentary, please click here.

Aug 4, 2016

Tomas Philipson in Forbes: Are You Just a Number?

In Tomas Phillipson's latest commentary (with Precision co-author Jason Shafrin), the development of new value framework criteria and it's impact on both patients and physicians are examined.

To read the complete commentary, please click here.

Jul 14, 2016

Philipson in Forbes: "If It Ain't Broke, Don't Fix It"

In Tomas Philipson's latest Op-Ed for, he addresses pharmaceutical innovation and the recent open letter by the UAEM: "If It Ain't Broke, Don't Fix It."

To read the complete commentary, please click here.

Jul 11, 2016

Precision's Chung, MacEwan and Goldman in Health Affairs: "One Size Fits All?"

Precision's Adrienne Chung, Joanna MacEwan, and Dana Goldman address formulary policy in a new Health Affairs blog: "Does A ‘One-Size-Fits-All’ Formulary Policy Make Sense?"

To read the complete commentary, please click here.

Jul 7, 2016

Precision's Darius Lakdawalla in the AP: A Model for More Rational Drug Prices

Precision's Darius Lakdawalla is featured in The AP's Big Story, discussing the need for a more rational drug pricing model.

To read the complete story, please click here.

Jun 30, 2016

Goldman in Modern Healthcare: Take A Lesson From Vaccines

PHE's Dana Goldman, in his latest commentary for Modern Healthcare, suggests that improving access and pricing for generic drugs could be accomplished by taking a lesson from vaccine policy.

To read the complete article, please click here.

Jun 3, 2016

Philipson in Forbes: Give Tax Payers A Rebate for Medical Innovation?

In Tomas Philipson's latest commentary, he examines tax-funded R&D medical spending and the market value of that research.

Read the article here.

Jun, 2016

Precision's Renick In The Pink Sheet: Importance of Data

Will data be enough to support a new drug that battles COPD?  In a recent article in The Pink Sheet, Precision’s Dan Renick weighs in on the importance of data to understand the potential impact:

The Pink Sheet

May 30, 2016

Real World Superiority Data May Not Be Enough To Boost GSK's Breo I ...

Jun, 2016

Renick in The Pink Sheet: Showing Value at Launch for Competing Drugs

Precision’s Dan Renick comments in The Pink Sheet on the importance of showing value when there are competing drugs at the time of launch:

The Pink Sheet

May 30, 2016

GSK Leads Way With Real World Data, But Others Follow

By Emily Hayes


Executive S ...

Jun, 2016

Lakdawalla in AP's The Big Story: "Why Aren't You Shopping for Lower Prescription Drug Prices?"

Precision Health Economics founder and Chief Strategy Officer Darius Lakdawalla discusses the concept of shopping for the lowest prescription drug prices and "pharmacy apps" with Matthew Perrone of AP's The Big Story.

To read the article, please click here

May 31, 2016

PHE’s Goldman, Lakdawalla, and Philipson To Participate in BIO Panel

Precision Health Economics’ (PHE) Dana Goldman, Darius Lakdawalla, and Tomas Philipson will be featured in the BIO International Convention panel - The Future of Biosimilars: How Will Policy and Market Dynamics Impact Patient Value and Access in the US?

This panel will take place from 10:45a ...

May 20, 2016

Precision's Chandra and Shafrin Address Value Frameworks in JAMA

Precision Health Economics' Amitabh Chandra and Jason Shafrin, along with author Ravider Dhawan, examine the utility of cancer value frameworks in the latest edition of the Journal of the American Medical Association (JAMA).

To read the complete article, please click here.

May 20, 2016

Precision's Sharma in The Lancet: Liberating Data to Combat NCD's

Precision's Abhishek Sharma is a featured co-author in the latest version of The Lancet Diabetes & Endocrinology-- focusing on the challenges of collecting, analysing, and using data related to non-communicable diseases (NCD's).

To read the complete article, please click here.

May 17, 2016

Peter Neumann, Leader in Health Economics and Outcomes Research, Joins Precision Health Economics as Advisor

Los Angeles, May 17, 2016 -- Precision Health Economics (PHE), a global leader in health economic research, policy, and analytics, announced today that Peter Neumann, ScD has joined PHE in the role of principal scientific advisor.

Neumann is an internationally recognized thought leader and inn ...

May 12, 2016

Precision Researchers Prominently Featured in AJMC's Special Issue on HCV

Precision Health Economics authors are prominently featured in the May 2016, Special Issue on the Hepatitis C virus, released by The American Journal of Managed Care.

Four articles published in the journal feature PHE authors, including:

  • “Does Patient Cost Sharing for HCV Drug Make Sense ...

May 11, 2016

Precision To Have Strong Presence at ISPOR's 21st Annual International Meeting, Washington DC

Precision Health Economics (PHE) researchers and scientific advisors will once again have a very strong presence at ISPOR’s 21st Annual International Meeting in Washington DC from May 21-25, 2016. PHE experts will be teaching 2 short courses, moderating and speaking at 3 issue panels, present ...

May 9, 2016

Philipson in Forbes: "Speed and Safety at the FDA"

Tomas Philipson's latest Op-Ed examines generic drug approvals as well as speed and safety at the FDA.

To read the complete commentary, please click here.

Apr 13, 2016

Precision's Sharma in Boston Globe: Boston Drug Pricing Dozens of Times Higher Than Overseas

Precision's Abhishek Sharma is the lead author of a new study just published in The Journal of Pharmaceutical Policy and Practice (JPPP), recently cited in the Boston Globe's STAT Pharmalot Blog. The article highlights the findings of the study illustrating that drug prices in Boston are dozens ...

Apr 12, 2016

Precision at AMCP 2016!

Come visit the Precision Health Economics team and our Precision for Value colleagues at Booth 307 at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting, to be held at the Moscone Convention Center, San Francisco, CA.

Look for examples of our expertise in the following presentations ...

Apr 6, 2016

Precision’s Eric Druyts to Speak at the 2016 International Liver Congress

Precision Health Economics’ Director Eric Druyts, PhD (candidate) will be attending the 2016 International Liver Congress in Barcelona, Spain, April 13 to 17 as an invited speaker presenting with the World Health Organization (WHO). Eric Druyts will be presenting on network meta-analysis as a ...

Apr 5, 2016

Tomas Philipson in Forbes: Value in Healthcare

In Tomas Philipson's latest op-ed, he and co-author Anupam B. Jena suggest it's time to stop scratching the surface when it comes to value in healthcare.

To read the complete commentary, please click here.